Healthcare venture capital is growing: 13 latest deals

Venture capitalists poured $10.6 billion into healthcare startups in the first half of this year, putting 2018 on pace to be a record year for venture capital investing in healthcare, according to data from the MoneyTree report from PwC and CB Insights.

Here are 13 healthcare venture capital deals announced in the past month:

1. Ooda Health, a San Francisco-based healthcare payments startup, completed a $40.5 million funding round, led by Oak HC/FT and DFJ Venture Capital.

2. Palo Alto, Calif.-based cancer immunotherapy company Immune-Onc raised $33 million in Series B funding from Northern Light Venture Capital, Vivo Capital and the Stanford-StartX Fund.

3. Alydia Health, a Menlo Park, Calif.-based medical device company, raised $10 million in Series B funding led by the Global Health Investment Fund.

4. Tvardi Therapeutics, a Houston-based biopharmaceutical company focused on the development of STAT3 inhibitors, raised $9 million in Series A funding from undisclosed investors.

5. Galera Therapeutics, a Malvern, Pa.-based biotechnology company focused on the development of drugs targeting oxygen metabolic pathways with the potential to transform cancer radiotherapy, secured $150 million in a joint, oversubscribed Series C financing and royalty purchase agreement. The financing was led by Clarus.

6. New York City-based biotech startup MouSensor raised $3.3 million in seed funding co-led by imec.xpand and Alexandria Venture Investments.

7. Ceribell, a Mountain View, Calif.-based developer of a rapid response EEG system, completed a $35 million Series B financing led by Optimas Capital Partners Fund and The Rise Fund with participation by UCB and LivaNova.

8. Maven, a digital health startup and benefits platform focused on improving access to healthcare for women, raised $27 million in Series B funding led by Sequoia and Oak HC/FT.

9. Lyra Therapeutics, a Watertown, Mass.-based biotechnology company developing medicines designed to target ear, nose and throat diseases, raised $29.5 million in Series B funding led by Perceptive Advisors.

10. Proscia, a Philadelphia-based digital pathology startup, completed an $8.3 million Series A financing led by Flybridge Capital.

11. Cambridge, Mass.-based drug discovery startup KSQ Therapeutics raised $76 million in Series B funding led by Flagship Pioneering.

12. Akrevia Therapeutics, a Cambridge, Mass.-based immunotherapy company, raised $30 million in Series A funding led by F-Prime Capital Partners and Atlas Venture.

13. VelosBio, a San Diego-based biotechnology company focused on developing novel antibody-drug conjugates to treat hematological cancers and solid tumors, raised $58 million in Series A funding led by Arix Bioscience.

More articles on healthcare finance:

15 health systems with strong finances
Nurses call for Michigan hospital CEO to step down as possibility of bankruptcy looms
Dignity Health's net income more than doubles

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars